| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Ablation of liver Fxr results in an increased colonic mucus barrier in mice
|
Ijssennagger, Noortje
|
|
|
|
5 |
p.
|
artikel
|
| 2 |
ALBI grade: Evidence for an improved model for liver functional estimation in patients with hepatocellular carcinoma
|
Demirtas, Coskun O.
|
|
|
|
5 |
p.
|
artikel
|
| 3 |
A natural history study of paediatric non-alcoholic fatty liver disease over 10 years
|
Draijer, Laura
|
|
|
|
5 |
p.
|
artikel
|
| 4 |
Antagonism between wild-type and mutant β-catenin controls hepatoblastoma differentiation via fascin-1
|
Gest, Caroline
|
|
|
|
5 |
p.
|
artikel
|
| 5 |
Association of per- and polyfluoroalkyl substance exposure with fatty liver disease risk in US adults
|
Zhang, Xinyuan
|
|
|
|
5 |
p.
|
artikel
|
| 6 |
Autophagy-mediated reduction of miR-345 contributes to hepatic cystogenesis in polycystic liver disease
|
Masyuk, Tatyana
|
|
|
|
5 |
p.
|
artikel
|
| 7 |
B-cell activating factor and IL-21 levels predict treatment response in autoimmune hepatitis
|
Biewenga, Maaike
|
|
|
|
5 |
p.
|
artikel
|
| 8 |
Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals
|
Howe, Anita Y.M.
|
|
|
|
5 |
p.
|
artikel
|
| 9 |
Circulating indian hedgehog is a marker of the hepatocyte-TAZ pathway in experimental NASH and is elevated in humans with NASH
|
Moore, Mary Patricia
|
|
|
|
5 |
p.
|
artikel
|
| 10 |
Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease
|
Simão, André Lopes
|
|
|
|
5 |
p.
|
artikel
|
| 11 |
Cirrhosis management in a major referral center during COVID-19
|
Garrido, Isabel
|
|
|
|
5 |
p.
|
artikel
|
| 12 |
Comprehensive lipidomics reveals phenotypic differences in hepatic lipid turnover in ALD and NAFLD during alcohol intoxication ⋆
|
Israelsen, Mads
|
|
|
|
5 |
p.
|
artikel
|
| 13 |
Contents
|
|
|
|
|
5 |
p.
|
artikel
|
| 14 |
Contents
|
|
|
|
|
5 |
p.
|
artikel
|
| 15 |
Contents
|
|
|
|
|
5 |
p.
|
artikel
|
| 16 |
Contents
|
|
|
|
|
5 |
p.
|
artikel
|
| 17 |
Copyright and information
|
|
|
|
|
5 |
p.
|
artikel
|
| 18 |
Copyright and information
|
|
|
|
|
5 |
p. e1
|
artikel
|
| 19 |
Copyright and information
|
|
|
|
|
5 |
p.
|
artikel
|
| 20 |
Copyright and information
|
|
|
|
|
5 |
p.
|
artikel
|
| 21 |
Copyright and information
|
|
|
|
|
5 |
p.
|
artikel
|
| 22 |
Corrigendum to ‘A multicenter analysis of the role of prophylactic transfusion of blood products in patients with cirrhosis and esophageal varices undergoing endoscopic band ligation’ [JHEP Reports 6 (2021)]
|
Blasi, Annabel
|
|
|
|
5 |
p.
|
artikel
|
| 23 |
Corrigendum to ‘Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis’ [JHEP Reports 3 (2021) 100287]
|
Torp, Nikolaj
|
|
|
|
5 |
p.
|
artikel
|
| 24 |
Cost of non-alcoholic steatohepatitis in Europe and the USA: The GAIN study
|
O'Hara, Jamie
|
|
|
|
5 |
p.
|
artikel
|
| 25 |
Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis – The promise of DNA methylation and molecular biomarkers
|
Vedeld, Hege Marie
|
|
|
|
5 |
p.
|
artikel
|
| 26 |
Differential and organ-specific functions of organic solute transporter α and β in experimental cholestasis
|
van de Wiel, Sandra M.W.
|
|
|
|
5 |
p.
|
artikel
|
| 27 |
Dysregulated biomarkers of innate and adaptive immunity predict infections and disease progression in cirrhosis
|
Simbrunner, Benedikt
|
|
|
|
5 |
p.
|
artikel
|
| 28 |
Editorial Board
|
|
|
|
|
5 |
p. iii
|
artikel
|
| 29 |
Editorial Board
|
|
|
|
|
5 |
p. i
|
artikel
|
| 30 |
Editorial Board
|
|
|
|
|
5 |
p.
|
artikel
|
| 31 |
Editorial Board page
|
|
|
|
|
5 |
p.
|
artikel
|
| 32 |
Editorial Board page
|
|
|
|
|
5 |
p.
|
artikel
|
| 33 |
Editorial Board page
|
|
|
|
|
5 |
p.
|
artikel
|
| 34 |
Efficacy and safety of frontline systemic therapy for advanced HCC: A network meta-analysis of landmark phase III trials
|
Fulgenzi, Claudia Angela Maria
|
|
|
|
5 |
p.
|
artikel
|
| 35 |
Embracing basic and clinical innovation in hepatology
|
Schwabe, Robert F.
|
|
|
|
5 |
p. 343-344
|
artikel
|
| 36 |
Epigenetics of alcohol-related liver diseases
|
Habash, Nawras W.
|
|
|
|
5 |
p.
|
artikel
|
| 37 |
Erratum to “Approaches for patients with very high MELD scores”
|
Artru, Florent
|
|
|
|
5 |
p. 414
|
artikel
|
| 38 |
Estimating the clinical prevalence of Wilson’s disease in the UK
|
Wijayasiri, Pramudi
|
|
|
|
5 |
p.
|
artikel
|
| 39 |
Evidence for long-term association of virion-delivered HBV core protein with cccDNA independently of viral protein production
|
Lucifora, Julie
|
|
|
|
5 |
p.
|
artikel
|
| 40 |
Excellent outcomes with liver transplantation in hepatopulmonary syndrome across pre-transplant PaO2 spectrum
|
Kadry, Zakiyah
|
|
|
|
5 |
p.
|
artikel
|
| 41 |
External validation of the Toronto hepatocellular carcinoma risk index in a Swedish population
|
Åström, Hanne
|
|
|
|
5 |
p.
|
artikel
|
| 42 |
Features of resistance-associated substitutions after failure of multiple direct-acting antiviral regimens for hepatitis C
|
Itakura, Jun
|
|
|
|
5 |
p.
|
artikel
|
| 43 |
Fluctuating biomarkers in primary sclerosing cholangitis: A longitudinal comparison of alkaline phosphatase, liver stiffness, and ELF
|
Fossdal, Guri
|
|
|
|
5 |
p.
|
artikel
|
| 44 |
Granulocyte colony-stimulating factor for alcoholic hepatitis: A systematic review and meta-analysis of randomised controlled trials
|
Marot, Astrid
|
|
|
|
5 |
p.
|
artikel
|
| 45 |
Hepatitis B virus preS2Δ38–55 variants: A newly identified risk factor for hepatocellular carcinoma
|
Cohen, Damien
|
|
|
|
5 |
p.
|
artikel
|
| 46 |
Hepatocyte mARC1 promotes fatty liver disease
|
Lewis, Lara C.
|
|
|
|
5 |
p.
|
artikel
|
| 47 |
High precision-cut liver slice model to study cell-autonomous antiviral defense of hepatocytes within their microenvironment
|
Brugger, Marcus
|
|
|
|
5 |
p.
|
artikel
|
| 48 |
Impact of adjuvant sorafenib treatment after local ablation for HCC in the phase II SORAMIC trial
|
Seidensticker, Max
|
|
|
|
5 |
p.
|
artikel
|
| 49 |
Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic
|
Boettler, Tobias
|
|
|
|
5 |
p.
|
artikel
|
| 50 |
Infection prevention and control programme and COVID-19 measures: Effects on hospital-acquired infections in patients with cirrhosis
|
Di Cola, Simone
|
|
|
|
5 |
p.
|
artikel
|
| 51 |
International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria
|
Degroote, Helena
|
|
|
|
5 |
p.
|
artikel
|
| 52 |
Intrahepatic macrophage populations in the pathophysiology of primary sclerosing cholangitis
|
Chen, Yung-Yi
|
|
|
|
5 |
p. 369-376
|
artikel
|
| 53 |
Introduction to corrigendum to ‘Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis’ [JHEP Reports 3 (2021) 100287]
|
Torp, Nikolaj
|
|
|
|
5 |
p.
|
artikel
|
| 54 |
KIR/HLA genotypes confer susceptibility and progression in patients with autoimmune hepatitis
|
Umemura, Takeji
|
|
|
|
5 |
p. 353-360
|
artikel
|
| 55 |
Low haemoglobin level predicts early hospital readmission in patients with cirrhosis and acute decompensation
|
Pompili, Enrico
|
|
|
|
5 |
p.
|
artikel
|
| 56 |
Metabolic dysfunction-associated fatty liver disease increases risk of adverse outcomes in patients with chronic hepatitis B
|
van Kleef, Laurens A.
|
|
|
|
5 |
p.
|
artikel
|
| 57 |
Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease
|
McGlinchey, Aidan J.
|
|
|
|
5 |
p.
|
artikel
|
| 58 |
Mindfulness-based stress reduction may decrease stress, disease activity, and inflammatory cytokine levels in patients with autoimmune hepatitis
|
Alrabadi, Leina S.
|
|
|
|
5 |
p.
|
artikel
|
| 59 |
Molecular epidemiology and clinical characteristics of hepatitis D virus infection in Canada
|
Osiowy, Carla
|
|
|
|
5 |
p.
|
artikel
|
| 60 |
Non-alcoholic fatty liver disease: A patient guideline
|
Francque, Sven M.
|
|
|
|
5 |
p.
|
artikel
|
| 61 |
Nuclear deformation mediates liver cell mechanosensing in cirrhosis
|
Guixé-Muntet, Sergi
|
|
|
|
5 |
p.
|
artikel
|
| 62 |
Pathological bile acid concentrations in chronic cholestasis cause adipose mitochondrial defects
|
Zhou, Weinan
|
|
|
|
5 |
p.
|
artikel
|
| 63 |
Public health policies and alcohol-related liver disease
|
Ventura-Cots, Meritxell
|
|
|
|
5 |
p. 403-413
|
artikel
|
| 64 |
R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation
|
Costentin, Charlotte
|
|
|
|
5 |
p.
|
artikel
|
| 65 |
Recent advances in liver transplantation for cancer: The future of transplant oncology
|
Abreu, Phillipe
|
|
|
|
5 |
p. 377-391
|
artikel
|
| 66 |
Regenerating research and life
|
Schwabe, Robert F.
|
|
|
|
5 |
p.
|
artikel
|
| 67 |
Reply to: “Does ammonia really disrupt brain oxygen homeostasis?”
|
Hosford, Patrick S.
|
|
|
|
5 |
p.
|
artikel
|
| 68 |
Reply to: “The clinical advantage of fixed 8-mm diameter VCX stents over underdilated VTS stents is not established in refractory ascites”
|
Praktiknjo, Michael
|
|
|
|
5 |
p.
|
artikel
|
| 69 |
Rescue of infant progressive familial intrahepatic cholestasis type 3 mice by repeated dosing of AAV gene therapy
|
Weber, Nicholas D.
|
|
|
|
5 |
p.
|
artikel
|
| 70 |
Restoration of the gut microbiota is associated with a decreased risk of hepatic encephalopathy after TIPS
|
Li, Menghao
|
|
|
|
5 |
p.
|
artikel
|
| 71 |
Scaling-up hepatitis C screening and treatment in Swiss outpatient psychiatric settings: A cost-effectiveness analysis
|
Girardin, François
|
|
|
|
5 |
p.
|
artikel
|
| 72 |
Serum lipopolysaccharides predict advanced liver disease in the general population
|
Männistö, Ville
|
|
|
|
5 |
p. 345-352
|
artikel
|
| 73 |
Similar performance of liver stiffness measurement and liver surface nodularity for the detection of portal hypertension in patients with hepatocellular carcinoma
|
Souhami, Alexandra
|
|
|
|
5 |
p.
|
artikel
|
| 74 |
Stratification of patients in NASH clinical trials: A pitfall for trial success
|
Ampuero, Javier
|
|
|
|
5 |
p.
|
artikel
|
| 75 |
TAK1 deficiency promotes liver injury and tumorigenesis via ferroptosis and macrophage cGAS-STING signalling
|
Su, Wantong
|
|
|
|
5 |
p.
|
artikel
|
| 76 |
The clinical advantage of fixed 8-mm diameter VCX stents over underdilated VTS stents is not established in refractory ascites
|
Mansour, Sohaïb
|
|
|
|
5 |
p.
|
artikel
|
| 77 |
The mid-infrared spectroscopy: A novel non-invasive diagnostic tool for NASH diagnosis in severe obesity
|
Anty, Rodolphe
|
|
|
|
5 |
p. 361-368
|
artikel
|
| 78 |
The neurogliovascular unit in hepatic encephalopathy
|
Claeys, Wouter
|
|
|
|
5 |
p.
|
artikel
|
| 79 |
The role of cGAS-STING signalling in liver diseases
|
Chen, Ruihan
|
|
|
|
5 |
p.
|
artikel
|
| 80 |
Transcriptomic analysis across liver diseases reveals disease-modulating activation of constitutive androstane receptor in cholestasis
|
Mathur, Bhoomika
|
|
|
|
5 |
p.
|
artikel
|
| 81 |
Using CRISPR/Cas9 to model human liver disease
|
Alves-Bezerra, Michele
|
|
|
|
5 |
p. 392-402
|
artikel
|
| 82 |
Volatomic analysis identifies compounds that can stratify non-alcoholic fatty liver disease
|
Sinha, Rohit
|
|
|
|
5 |
p.
|
artikel
|
Tijdschrift beschrijving